Covishield
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
![Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP [Video]](https://video.newsserve.net/300/v/20240501/1374215868-Lok-Sabha-Elections-2024-SP-Chief-Akhilesh-Yadav.jpg) Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP Credit: Oneindia Duration: 02:44Published | |
![Side Effects Of COVID vaccine [Video]](https://video.newsserve.net/300/v/20240430/1714485390-Side-Effects-Of-COVID-vaccine.jpg) Side Effects Of COVID vaccine Credit: Rumble Duration: 00:11Published | |
You Might Like
AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield.DNA - Published | |
AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concernsIn light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while..DNA - Published | |
AstraZeneca admits its COVID-19 vaccine Covishield can cause rare...Covishield was developed by AstraZeneca in collaboration with the Oxford University during the COVID-19 pandemicDNA - Published Also reported by •IndiaTimes | |
Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is..He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.DNA - Published | |
Take down defamatory posts on Covishield: Bombay high courtIndiaTimes - Published | |
Bombay HC says content posted against Covishield vaccine prima facie defamatoryThe Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..Mid-Day - Published | |
Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HCThe Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..IndiaTimes - Published Also reported by •Mid-Day | |
SII to restart vaccine production amid surge in Covid casesSerum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..IndiaTimes - Published | |
Serum Institute of India restarts manufacturing of Covid-19 vaccine CovishieldSerum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..IndiaTimes - Published | |
Record Breaking 'Hero' Gives Maximum Vaccine Doses, on Track to Beat the Pandemic *India Book of Records* strives to be a valuable resource of inspiration for people around the country, as it celebrates and honours the incredible feats and accomplishments of people in various fields..NewsVoir - Published | |
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseCovovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..IndiaTimes - Published | |
Booster dose of Covishield offers best immune response: Lancet studyIndiaTimes - Published | |
Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsCovid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two..Zee News - Published | UP gets fresh supply for Covishield vax dosesnewKerala.com - Published |
Covid-19: Govt admits multiple side-effects of coronavirus vaccines in RTI replyIn the reply to an RTI filed by a Pune businessman, ICMR and CDSCO have admitted to multiple side effects of Covid-19 vaccination and the Covishield which was among the first vaccines approved by..Zee News - Published | Do you need 4th dose of COVID vaccine?The study was conducted on the participants who had received the booster dose of the Covishield vaccination.IndiaTimes - Published |
Drug panel favours nod for Covovax as Covid boosterAn expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..IndiaTimes - Published | Covovax may get approval as heterologous boosterThe government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..IndiaTimes - Published |
Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar PoonawallaSerum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the..IndiaTimes - Published | Himachal seeks 10 lakh doses of CovishieldnewKerala.com - Published |
Covid-19: Vaccination figures jump three-fold in MumbaiGovt-run centres only have Covaxin; state writes to Centre seeking Covishield, CorbevaxMid-Day - Published | Serum Institute to provide 2 crore Covishield doses to central govt free of costIndiaTimes - Published |
Bharat Biotech's nasal vaccine to be priced at Rs 800/dose in pvt markets, Rs 325/dose for governmentsBharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for central and state governments. The company..IndiaTimes - Published | No shortage of Covishield, says PoonawallaIndiaTimes - Published |
Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are availableNoida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose.DNA - Published | Explained: Covid-19 nasal vaccine available now, know how it works and who can takeThe nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin.DNA - Published |
Adar Poonawallah`s IMPORTANT MESSAGE amid Covid outbreak in ChinaAmid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic. Serum Institute of India is the one who..Zee News - Published | Mumbai: No takers, no stock for Covid-19 vaccinesWith interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin leftMid-Day - Published |
Covishield vaccine complication: Kerala HC issues notice to SII, state, CentrenewKerala.com - Published | People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla"Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla..Zee News - Published |
SII stopped production of Covishield vaccine since December 2021, says CEO Adar PoonwallanewKerala.com - Published | No takers for boosters, 100m Covishield doses dumped: SIIIndiaTimes - Published |
Mumbai: Booster shot takers saying no to CorbevaxAmid shortage of Covishield doses, civic officials offer Corbevax, but people are hesitant to take the brand’s COVID vaccineMid-Day - Published | Bill Gates, SII get Bombay High Court notice as petitioner claims Covishield killed his daughterThe petitioner blamed the authorities for creating false narratives about the Covishield vaccine. He has sought compensation of Rs 1,000 crore.DNA - Published |
Covishield usage highest as precaution dose for Covid-19 compared to other vaccinesnewKerala.com - Published | Govt: Sputnik V recipients can take Covishield, Covaxin boosterIndiaTimes - Published |
India widens Covid-19 vaccine basket, Corbevax to be available as booster dose for all adults from THIS dateThose adults who got vaccinated with either Covaxin or Covishield will now be allowed to take the Corbevax dose, six months or 26 weeks after administration of the second dose.Zee News - Published | Corbevax approved as precaution dose for adults vaccinated with Covaxin, CovishieldnewKerala.com - Published Also reported by •Indian Express •DNA |
Corbevax gets nod as booster after Covishield, Covaxin shotsIndiaTimes - Published | India to start Covid mix-and-match booster vaccines on FridayIndia said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..IndiaTimes - Published |
Mix and match: Centre okays Corbevax as booster for those who got Covishield or CovaxinIndian Express - Published | |
